References
- Zaidi AK, Ganatra HA, Syed S, Cousens S, Lee AC, Black R, Bhutta ZA, Lawn JE. Effect of case management on neonatal mortality due to sepsis and pneumonia. BMC Public Health 2011;11 Suppl 3:S13.
- Weston EJ, Pondo T, Lewis MM, Martell-Cleary P, Morin C, Jewell B, Daily P, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J 2011;30:937–941.
- Russell JA. Management of sepsis. N Engl J Med 2006;355:1699–1713.
- Ng PC, Li K, Leung TF, Wong RP, Li G, Chui KM, Wong E, et al. Early prediction of sepsis-induced disseminated intravascular coagulation with interleukin-10, interleukin-6, and RANTES in preterm infants. Clin Chem 2006;52:1181–1189.
- Hofer N, Zacharias E, Müller W, Resch B. An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks. Neonatology 2012;102:25–36.
- Chiesa C, Natale F, Pascone R, Osborn JF, Pacifico L, Bonci E, De Curtis M. C reactive protein and procalcitonin: reference intervals for preterm and term newborns during the early neonatal period. Clin Chim Acta 2011;412:1053–1059.
- Fraser CG, Hyltoft Petersen P, Libeer JC, Ricos C. Proposals for setting generally applicable quality goals solely based on biology. Ann Clin Biochem 1997;34 (Pt 1):8–12.
- Clark GH, Fraser CG. Biological variation of acute phase proteins. Ann Clin Biochem 1993;30 (Pt 4):373–376.
- Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 1997;43:52–58.
- Braga F, Panteghini M. Biologic variability of C-reactive protein: is the available information reliable? Clin Chim Acta 2012;413:1179–1183.
- Kaplan RS, Porter ME. How to solve the cost crisis in health care. Harv Bus Rev 2011;89:46–52, 54, 56.
- Price CP. Roots, development and future directions of laboratory medicine. Clin Chem Lab Med 2010;48:903–909.